Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO

Completed · Phase 4

Conditions studied: Hepatitis C, Chronic

In brief

This is a Phase IV, open-label, multi-center study to evaluate the real world sustained virological response rate, subject adherence, and subject reported outcomes during and after treatment of non-cirrhotic genotype 1 chronic hepatitis C subjects aged 18 years and older, with VIEKIRA PAK (ombitasvir, paritaprevir/r, dasabuvir), with or without RBV (ribavirin).

Key facts

Study ID

NCT02461745

Run by

Kaiser Permanente

People needed

200

Starts

2015-06-01

Expected to finish

2017-05-01

Last updated by the study team

2021-01-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Kaiser Permanente Medical Center — Irvine, California, United States
• Kaiser Permanente Medical Center — Los Angeles, California, United States
• Kaiser Permanente Medical Center — San Diego, California, United States
• Kaiser Permanente Medical Center — San Marcos, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.